Three drugs have recently been approved by the FDA in the treatment and prevention of migraines – Aimovig™, AJOVY™, and Emgality™. Each targets CGRP (Calcitonin Gene Related Peptide) receptors, which is a completely new way to treat migraines. They are injectable and have been proven effective while also having low side effects. Kane Hall Barry Neurology is committed to helping our patients with migraines.
If you suffer with migraines, please make an appointment with one of our providers to discuss your options.